Interferon monotherapy for dialysis patients with chronic hepatitis C: an analysis of the literature on efficacy and safety.
about
Interferon for Hepatitis C Virus in Hemodialysis--an Individual Patient Meta-analysis of Factors Associated with Sustained Virological ResponseManaging chronic hepatitis C in the difficult-to-treat patientConsensus Statement of HCV Task Force of the Indian National Association for Study of the Liver (INASL). Part II: INASL Recommendations for Management of HCV in India.Treatment of hepatitis C virus infectionManagement of hepatitis C in patients with chronic kidney disease.How to Review a Meta-analysisHepatitis C and kidney transplantationManagement of patients with hepatitis C infection and renal disease.Kidney transplantation from donors with hepatitis C infection.Hepatitis C in hemodialysis patientsIncidence of CMV-HCV coinfection in renal transplant recipient.Management of chronic hepatitis C: consensus guidelines.Superior outcomes in HIV-positive kidney transplant patients compared with HCV-infected or HIV/HCV-coinfected recipientsLack of Efficacy of Pegylated Interferon Monotherapy for Hepatitis C in Patients With End-Stage Renal Disease on Dialysis.Efficacy and tolerability of low-dose interferon-α in hemodialysis patients with chronic hepatitis C virus infection.Dilemma of HCV infection in renal transplant recipients.Hepatitis C infection in renal transplantation: pathogenesis, current impact and emerging trends.Chronic hepatitis C
P2860
Q27489433-D386D3AA-3156-4D6B-9C75-861A8A7F08EDQ27490409-78E33CF1-75A9-481E-8BA0-52ED0512940BQ30417045-384E3445-A00E-4EDE-8BA7-079AE858F0EFQ34099424-59381079-1021-4050-A1B4-1B7BB31A7CEEQ34932338-B955BC1A-E0C0-40EF-A3BC-6D30DECB2D9BQ34996708-E6F8B858-F075-445D-8F64-D190C24B036EQ35094769-E7D4B586-89CD-48DE-A868-2CE05BDA2452Q35127041-35DC6F22-391D-4B33-8A52-AF0BD82CCF07Q35128555-41EC9813-37D6-484B-9009-42C37DA447A9Q35237329-7CEFA464-0FDE-490A-933C-C84D93B4405FQ35919439-4E7A1DD6-078E-462D-B797-75A8E7908652Q36849347-9AB5D3F9-AEA0-45C9-9ECF-D0CCDF9D3FCCQ37420014-01422D6D-B855-4593-925D-377B9188B9A7Q37692546-797B95C9-D9C6-491E-A536-A83AF4583479Q37697588-0E82E654-4CFE-43F8-8732-FC4C965CB650Q37887523-25738EEE-ED23-4196-9519-2F839604C272Q47559302-86B9FF2B-9133-42C2-966C-EC2298222977Q56929229-CA6D3CF2-9BDF-476D-B207-8927CB472A94
P2860
Interferon monotherapy for dialysis patients with chronic hepatitis C: an analysis of the literature on efficacy and safety.
description
2003 nî lūn-bûn
@nan
2003 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Interferon monotherapy for dia ...... rature on efficacy and safety.
@ast
Interferon monotherapy for dia ...... rature on efficacy and safety.
@en
type
label
Interferon monotherapy for dia ...... rature on efficacy and safety.
@ast
Interferon monotherapy for dia ...... rature on efficacy and safety.
@en
prefLabel
Interferon monotherapy for dia ...... rature on efficacy and safety.
@ast
Interferon monotherapy for dia ...... rature on efficacy and safety.
@en
P2093
P1476
Interferon monotherapy for dia ...... rature on efficacy and safety.
@en
P2093
Craig D Goldsweig
Ira M Jacobson
Mark W Russo
Robert S Brown
P304
P356
10.1016/S0002-9270(03)00308-3
P407
P577
2003-07-01T00:00:00Z